简介：
Overview
This study presents a protocol for modeling neonatal sepsis in mice using bioluminescent E. coli O1:K1:H7. The method allows for real-time tracking of bacterial dissemination and correlating disease markers with pathogen burden.
Key Study Components
Area of Science
- Neonatal sepsis
- Infectious diseases
- Immunology
Background
- Neonatal sepsis is a critical condition affecting newborns.
- Understanding the dynamics of bacterial infections in neonates is essential for developing treatments.
- Bioluminescent bacteria provide a unique tool for real-time imaging of infections.
- Current models lack the ability to longitudinally analyze infection dynamics.
Purpose of Study
- To develop a protocol for studying neonatal sepsis in real time.
- To correlate bacterial burden with inflammatory responses and lung pathology.
- To facilitate preclinical testing of interventions for neonatal sepsis.
Methods Used
- Inoculation of neonatal mice with bioluminescent E. coli.
- Longitudinal intravital imaging to track infection dynamics.
- Enumeration of systemic bacterial burdens.
- Inflammatory profiling and lung histopathology analysis.
Main Results
- Significant pulmonary inflammation and lung pathology observed.
- Real-time tracking of bacterial dissemination achieved.
- Correlation between bacterial burden and inflammatory markers established.
- Protocol enables monitoring of host responses to infection.
Conclusions
- The developed protocol is effective for studying neonatal sepsis.
- Real-time imaging enhances understanding of infection dynamics.
- This model can aid in the development of therapeutic strategies for neonatal sepsis.
What is the significance of using bioluminescent E. coli?
Bioluminescent E. coli allows for real-time tracking of bacterial infections in live animals, providing insights into infection dynamics.
How does this model help in preclinical testing?
The model enables researchers to observe the effects of potential treatments on bacterial burden and host responses in real time.
What are the main outcomes measured in this study?
Outcomes include bacterial burden, inflammatory responses, and lung pathology in neonatal mice.
Can this protocol be adapted for other pathogens?
Yes, the protocol can be modified to study different pathogens affecting neonatal health.
What age of neonatal mice is used in this study?
The study uses age-matched pups on postnatal days three or four for inoculation.
What safety measures are taken during the experiment?
Experiments are conducted in a biosafety level two cabinet to ensure safety when handling infectious agents.
繁體中文
